An in situ molecular signature to predict early recurrence in hepatitis B virus-related hepatocellular carcinoma

Journal of Hepatology

Volumn 57, Issue 2, 2012, Pages 313-321

  Xu, Jing ^a   Ding, Tong ^a,c   He, Qi ^b   Yu, Xing Juan ^a   Wu, Wen Chao ^a   Jia, Wei Hua ^b   Yun, Jing Ping ^a,b   Zhang, Ying ^b   Shi, Ming ^b   Shao, Chun Kui ^b   Pan, Wei Dong ^b   Yin, Xiao Yu ^b   Min, Jun ^b   Zhuang, Shi Mei ^b   Zheng, Limin ^a,b  

^a SUN YAT SEN UNIVERSITY CANCER CENTER   (China)

^b SUN YAT SEN UNIVERSITY   (China)

^c NANJING MEDICAL UNIVERSITY   (China)

Author keywords

Classifier; Hepatocellular carcinoma; Immunohistochemistry; Microenvironment; Prognosis

Indexed keywords

B7 ANTIGEN; CYCLIN D1; CYTOKERATIN 19; FAS LIGAND; HLA DR ANTIGEN; KI 67 ANTIGEN; MOLECULAR MARKER; PROTEIN BCL 2;

ADULT; ADVANCED CANCER; AGED; ALGORITHM; ARTICLE; CANCER INVASION; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; FOLLOW UP; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS B VIRUS RELATED LIVER CELL CARCINOMA; HIGH RISK PATIENT; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; METASTASIS; OVERALL SURVIVAL; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RISK ASSESSMENT; TISSUE MICROARRAY; TUMOR VOLUME;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, HEPATOCELLULAR; FEMALE; GENE EXPRESSION PROFILING; HEPATITIS B; HUMANS; IMMUNOHISTOCHEMISTRY; LIVER NEOPLASMS; LOGISTIC MODELS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; TISSUE ARRAY ANALYSIS;

EID: 84863987629     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2012.03.027     Document Type: Article

References (36)

1. A. Jemal, F. Bray, M.M. Center, J. Ferlay, E. Ward, and D. Forman Global cancer statistics CA Cancer J Clin 61 2011 69 90
2. J.D. Yang, and L.R. Roberts Hepatocellular carcinoma: a global view Nat Rev Gastroenterol Hepatol 7 2010 448 458
3. D. Poon, B.O. Anderson, L.T. Chen, K. Tanaka, W.Y. Lau, and E. Van Cutsem Management of hepatocellular carcinoma in Asia: consensus statement from the Asian Oncology Summit 2009 Lancet Oncol 10 2009 1111 1118
4. S.T. Fan, C. Mau Lo, R.T. Poon, C. Yeung, C. Leung Liu, and W.K. Yuen Continuous improvement of survival outcomes of resection of hepatocellular carcinoma: a 20-year experience Ann Surg 253 2011 745 758
5. J. Bruix, and J.M. Llovet Major achievements in hepatocellular carcinoma Lancet 373 2009 614 616
6. A. Villanueva, Y. Hoshida, S. Toffanin, A. Lachenmayer, C. Alsinet, and R. Savic New strategies in hepatocellular carcinoma: genomic prognostic markers Clin Cancer Res 16 2010 4688 4694
7. S. Yoshioka, I. Takemasa, H. Nagano, N. Kittaka, T. Noda, and H. Wada Molecular prediction of early recurrence after resection of hepatocellular carcinoma Eur J Cancer 45 2009 881 889
8. Y. Hoshida Nearest template prediction: a single-sample-based flexible class prediction with confidence assessment PLoS One 5 2010 e15543
9. A. Villanueva, Y. Hoshida, C. Battiston, V. Tovar, D. Sia, and C. Alsinet Combining clinical, pathology, and gene expression data to predict recurrence of hepatocellular carcinoma Gastroenterology 140 2011 1501 1512 e2
10. J.U. Marguardt, P.R. Galle, and A. Teufel Molecular diagnosis and therapy of hepatocellular carcinoma (HCC): an emerging field for advanced technologies J Hepatol 56 2012 267 275
11. Z.H. Zhu, B.Y. Sun, Y. Ma, J.Y. Shao, H. Long, and X. Zhang Three immunomarkers support vector machines-based prognostic classifiers for stage IB non-small cell lung cancer J Clin Oncol 27 2009 1091 1099
12. H. van Malenstein, J. van Pelt, and C. Verslype Molecular classification of hepatocellular carcinoma anno 2011 Eur J Cancer 47 2011 1789 1797
13. B.E. Gould Rothberg, M.B. Bracken, and D.L. Rimm Tissue biomarkers for prognosis in cutaneous melanoma: a systematic review and meta-analysis J Nat Cancer Inst 101 2009 452 474
14. W.W. Choi, D.D. Weisenburger, T.C. Greiner, M.A. Piris, A.H. Banham, and J. Delabie A new immunostain algorithm classifies diffuse large B-cell lymphoma into molecular subtypes with high accuracy Clin Cancer Res 15 2009 5494 5502
15. V. Chew, C. Tow, M. Teo, H.L. Wong, J. Chan, and A. Gehring Inflammatory tumor microenvironment is associated with superior survival in hepatocellular carcinoma patients J Hepatol 52 2010 370 379
16. A. Budhu, M. Forgues, Q.H. Ye, H.L. Jia, P. He, and K.A. Zanetti Prediction of venous metastases, recurrence, and prognosis in hepatocellular carcinoma based on a unique immune response signature of the liver microenvironment Cancer Cell 10 2006 99 111
17. D.M. Kuang, Q. Zhao, C. Peng, J. Xu, J.P. Zhang, and C. Wu Activated monocytes in peritumoral stroma of hepatocellular carcinoma foster immune privilege and disease progression through PD-L1 J Exp Med 206 2009 1327 1337
18. D.M. Kuang, Q. Zhao, Y. Wu, C. Peng, J. Wang, and Z. Xu Peritumoral neutrophils link inflammatory response to disease progression by fostering angiogenesis in hepatocellular carcinoma J Hepatol 54 2011 948 955
19. Q. Gao, S.J. Qiu, J. Fan, J. Zhou, X.Y. Wang, and Y.S. Xiao Intratumoral balance of regulatory and cytotoxic T cells is associated with prognosis of hepatocellular carcinoma after resection J Clin Oncol 25 2007 2586 2593
20. T. Ding, J. Xu, Y. Zhang, R.P. Guo, W.C. Wu, and S.D. Zhang Endothelium-coated tumor clusters are associated with poor prognosis and micrometastasis of hepatocellular carcinoma after resection Cancer 117 2011 4878 4889
21. J.P. Zhang, J. Yan, J. Xu, X.H. Pang, M.S. Chen, and L. Li Increased intratumoral IL-17-producing cells correlate with poor survival in hepatocellular carcinoma patients J Hepatol 50 2009 980 989
22. T. Ding, J. Xu, F. Wang, M. Shi, Y. Zhang, and S.P. Li High tumor-infiltrating macrophage density predicts poor prognosis in patients with primary hepatocellular carcinoma after resection Hum Pathol 40 2009 381 389
23. C. Decaestecker, X.M. Lopez, N. D'Haene, I. Roland, S. Guendouz, and C. Duponchelle Requirements for the valid quantification of immunostains on tissue microarray materials using image analysis Proteomic 9 2009 4478 4494
24. N.J. Perkins, and E.F. Schisterman The inconsistency of "optimal" cutpoints obtained using two criteria based on the receiver operating characteristic curve Am J Epidemiol 163 2006 670 675
25. R.T. Poon, S.T. Fan, I.O. Ng, C.M. Lo, C.L. Liu, and J. Wong Different risk factors and prognosis for early and late intrahepatic recurrence after resection of hepatocellular carcinoma Cancer 89 2000 500 507
26. H.C. Sun, W. Zhang, L.X. Qin, B.H. Zhang, Q.H. Ye, and L. Wang Positive serum hepatitis B e antigen is associated with higher risk of early recurrence and poorer survival in patients after curative resection of hepatitis B-related hepatocellular carcinoma J Hepatol 47 2007 684 690
27. W.S. Noble What is a support vector machine? Nat Biotechnol 24 2006 1565 1567
28. M.P. Brown, W.N. Grundy, D. Lin, N. Cristianini, C.W. Sugnet, and T.S. Furey Knowledge-based analysis of microarray gene expression data by using support vector machines Proc Natl Acad Sci U S A 97 2000 262 267
29. J.M. Bueno-de-Mesquita, W.H. van Harten, V.P. Retel, L.J. Van't Veer, F.S. van Dam, and K. Karsenberg Use of 70-gene signature to predict prognosis of patients with node-negative breast cancer: a prospective community-based feasibility study (RASTER) Lancet Oncol 8 2007 1079 1087
30. B. Mlecnik, M. Tosolini, A. Kirilovsky, A. Berger, G. Bindea, and T. Meatchi Histopathologic-based prognostic factors of colorectal cancers are associated with the state of the local immune reaction J Clin Oncol 29 2011 610 618
31. X.R. Yang, Y. Xu, B. Yu, J. Zhou, S.J. Qiu, and G.M. Shi High expression levels of putative hepatic stem/progenitor cell biomarkers related to tumor angiogenesis and poor prognosis of hepatocellular carcinoma Gut 59 2010 953 962
32. D. de Jong, A. Rosenwald, M. Chhanabhai, P. Gaulard, W. Klapper, and A. Lee Immunohistochemical prognostic markers in diffuse large B-cell lymphoma: validation of tissue microarray as a prerequisite for broad clinical applications - a study from the Lunenburg lymphoma biomarker consortium J Clin Oncol 25 2007 805 812
33. Y. Hoshida, A. Villanueva, M. Kobayashi, J. Peix, D.Y. Chiang, and A. Camargo Gene expression in fixed tissues and outcome in hepatocellular carcinoma N Engl J Med 359 2008 1995 2004
34. J.F. Ji, J. Shi, A. Budhu, Z.P. Yu, M. Forgues, and S. Roessler MicroRNA expression, survival, and response to interferon in liver cancer N Engl J Med 361 2009 1437 1447
35. H. Kim, G.H. Choi, D.C. Na, E.Y. Ahn, and G.I. Kim Human hepatocellular carcinomas with "Stemness"-related marker expression: keratin 19 expression and a poor prognosis Hepatology 54 2011 1707 1717
36. N. Portolani, A. Coniglio, S. Ghidoni, M. Giovanelli, A. Benetti, and G.A. Tiberio Early and late recurrence after liver resection for hepatocellular carcinoma: prognostic and therapeutic implications Ann Surg 243 2006 229 235